Genetic Variation, C-Reactive Protein Levels, and Incidence of Diabetes, Diabetes, vol.56, issue.3, pp.56-872, 2007. ,
DOI : 10.2337/db06-0922
C-Reactive Protein Is an Independent Predictor of Risk for the Development of Diabetes in the West of Scotland Coronary Prevention Study, Diabetes, vol.51, issue.5, pp.51-1596, 2002. ,
DOI : 10.2337/diabetes.51.5.1596
Inflammatory Markers, Adiponectin, and Risk of Type 2 Diabetes in the Pima Indian, Diabetes Care, vol.26, issue.6, pp.1745-1751, 2003. ,
DOI : 10.2337/diacare.26.6.1745
C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men, Diabetologia, vol.47, issue.8, pp.47-1403, 2004. ,
DOI : 10.1007/s00125-004-1472-x
Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis, Diabetologia, vol.52, pp.1040-1047, 2009. ,
A Prospective Study of Inflammatory Cytokines and Diabetes Mellitus in a Multiethnic Cohort of Postmenopausal Women, Archives of Internal Medicine, vol.167, issue.15, pp.1676-1685, 2007. ,
DOI : 10.1001/archinte.167.15.1676
Sex Differences in the Prediction of Type 2 Diabetes by Inflammatory Markers: Results from the MONICA/KORA Augsburg case-cohort study, 1984-2002, Diabetes Care, vol.30, issue.4, pp.854-860, 1984. ,
DOI : 10.2337/dc06-1693
Tissue plasminogen activator, von Willebrand factor, and risk of type 2 diabetes in older men. Diabetes Care, pp.31-995, 2008. ,
C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease, New England Journal of Medicine, vol.350, issue.14, pp.1387-1397, 2004. ,
DOI : 10.1056/NEJMoa032804
Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts, International Journal of Epidemiology, vol.38, issue.1, pp.217-231, 2009. ,
DOI : 10.1093/ije/dyn217
Inflammation and metabolic disorders, Nature, vol.314, issue.7121, pp.860-867, 2006. ,
DOI : 10.1038/nature05485
Association of Carotid Artery Intima-Media Thickness, Plaques, and C-Reactive Protein With Future Cardiovascular Disease and All-Cause Mortality: The Cardiovascular Health Study, Circulation, vol.116, issue.1, pp.32-38, 2007. ,
DOI : 10.1161/CIRCULATIONAHA.106.645606
On the use of Mendelian randomization to infer causality in observational epidemiology, European Heart Journal, vol.29, issue.20, pp.2456-2457, 2008. ,
DOI : 10.1093/eurheartj/ehn428
Inflammation, Insulin Resistance, and Diabetes???Mendelian Randomization Using CRP Haplotypes Points Upstream, PLoS Medicine, vol.53, issue.8, p.155, 2008. ,
DOI : 10.1371/journal.pmed.0050155.st002
C-reactive protein and its role in metabolic syndrome: mendelian randomisation study, Lancet, vol.366, pp.1954-1959, 2005. ,
A C-reactive protein promoter polymorphism is associated with type 2 diabetes mellitus in Pima Indians, Molecular Genetics and Metabolism, vol.78, issue.2, pp.78-136, 2003. ,
DOI : 10.1016/S1096-7192(02)00230-5
Genetic Loci Associated With C-Reactive Protein Levels and Risk of Coronary Heart Disease, JAMA, vol.302, issue.1, pp.37-48, 2009. ,
DOI : 10.1001/jama.2009.954
Does high C-reactive protein concentration increase atherosclerosis? The Whitehall II Study PLoS ONE, p.3013, 2008. ,
The association of C-reactive protein and CRP genotype with coronary heart disease: findings from five studies with 4, PLoS ONE, vol.637, issue.3, pp.610-628, 2008. ,
Genetically Elevated C-Reactive Protein and Ischemic Vascular Disease, New England Journal of Medicine, vol.359, issue.18, pp.1897-1908, 2008. ,
DOI : 10.1056/NEJMoa0707402
Cohort Profile: The Whitehall II study, International Journal of Epidemiology, vol.34, issue.2, pp.251-256, 2005. ,
DOI : 10.1093/ije/dyh372
Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation, Diabetic Medicine, vol.15, issue.7, pp.15-539, 1998. ,
DOI : 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
Association of Socioeconomic Position With Health Behaviors and Mortality, JAMA, vol.303, issue.12, pp.1159-1166, 2010. ,
DOI : 10.1001/jama.2010.297
URL : https://hal.archives-ouvertes.fr/inserm-00468691
Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence Elevated levels of the anti-inflammatory interleukin-1 receptor antagonist (IL-1Ra) precede the onset of type 2 diabetes (Whitehall II Study) Diabetes Care, pp.421-423, 2003. ,
Effects of Antidiabetic and Antihyperlipidemic Agents on C-Reactive Protein, Mayo Clinic Proceedings, vol.83, issue.3, pp.333-342, 2008. ,
DOI : 10.4065/83.3.333
Diet-quality scores and plasma concentrations of markers of inflammation and endothelial dysfunction, American Journal of Clinical Nutrition, vol.82, pp.163-173, 2005. ,
The Effects of Physical Activity on Serum C-Reactive Protein and Inflammatory Markers, Journal of the American College of Cardiology, vol.45, issue.10, pp.1563-1569, 2005. ,
DOI : 10.1016/j.jacc.2004.12.077
The Effect of Weight Loss on C-Reactive Protein, Archives of Internal Medicine, vol.167, issue.1, pp.31-39, 2007. ,
DOI : 10.1001/archinte.167.1.31